Showing results (61-70 of 322) with videos related to
Sort By:
Pageof 33
Scandinavian Journal of Infectious Diseases|January 1, 1992
Foscarnet for treatment of cytomegalovirus infections in bone marrow transplant recipientsJ Aschan, O Ringdén, P Ljungman, et al.Transplantation|November 1, 1985
Lymphocyte responses after cytomegalovirus infection in bone marrow transplant recipients--a one-year follow-upP Ljungman, B Lönnqvist, B Wahren, et al.Cancer Nursing|October 1, 1996
Health-related quality of life in women with breast cancer undergoing autologous stem-cell transplantationJ Larsen, A Gardulf, G Nordström, et al.Acta Medica Scandinavica|January 1, 1986
Bone marrow transplantation in three patients with multiple myelomaG Gahrton, O Ringdén, B Lönnqvist, et al.Blood|March 15, 1996
The development of cellular immunity to Epstein-Barr virus after allogeneic bone marrow transplantationK G Lucas, T N Small, G Heller, et al.Bone Marrow Transplantation|June 1, 1995
Busulfan concentration in relation to permanent alopecia in recipients of bone marrow transplantsP Ljungman, M Hassan, A N Békássy, et al.Bone Marrow Transplantation|August 1, 1996
Loss of seroreactivity against human papillomavirus (HPV) in bone marrow transplant recipientsI Lewensohn-Fuchs, P Ljungman, A Kjerrström, et al.Bone Marrow Transplantation|March 1, 1995
Double high-dose chemoradiotherapy with autologous stem cell transplantation can induce molecular remissions in multiple myelomaB Björkstrand, P Ljungman, J M Bird, et al.Bone Marrow Transplantation|May 1, 1995
Bone marrow transplantation in two children with congenital amegakaryocytic thrombocytopeniaJ I Henter, J Winiarski, P Ljungman, et al.Bone Marrow Transplantation|January 9, 1998
High busulfan concentrations are associated with increased transplant-related mortality in allogeneic bone marrow transplant patientsP Ljungman, M Hassan, A N Békássy, et al.Pageof 33